| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncorus, Inc. | Director | Stock Option (right to buy) | 25K | 22 Jun 2022 | Direct | ||
| Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Common Stock | 0 | $38.25 | 28 Dec 2021 | Direct | |
| Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Restricted Stock Units | 0 | 28 Dec 2021 | Direct | ||
| Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Employee Stock Option (Right to Buy) | 0 | 28 Dec 2021 | By Trust | ||
| Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Employee Stock Option (Right to Buy) | 0 | 28 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ONCR | Oncorus, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 06:33 |
| ONCR | Oncorus, Inc. | 22 Jun 2022 | 0 | $0 | 3 | Director | 24 Jun 2022, 06:30 |
| DRNA | Dicerna Pharmaceuticals Inc | 28 Dec 2021 | 15 | -$8.85M | 4 | Chief Executive Officer, Director | 29 Dec 2021, 15:19 |
| DRNA | Dicerna Pharmaceuticals Inc | 15 Dec 2021 | 3 | -$203K | 4 | Chief Executive Officer, Director | 17 Dec 2021, 15:16 |
| DRNA | Dicerna Pharmaceuticals Inc | 10 Dec 2021 | 4 | $600K | 4 | Chief Executive Officer, Director | 13 Dec 2021, 18:33 |
| DRNA | Dicerna Pharmaceuticals Inc | 10 Aug 2021 | 1 | $110K | 4 | President and CEO, Director | 10 Aug 2021, 20:06 |